Lukas Shumway
Stock Analyst at Barclays
(2.95)
# 2,777
Out of 4,690 analysts
14
Total ratings
69.2%
Success rate
10.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lukas Shumway
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintained: Buy | $56 | $20.45 | +173.84% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Maintained: Buy | $36 | $27.57 | +30.58% | 4 | Aug 11, 2026 | |
| DRTS Alpha Tau Medical | Maintained: Buy | $17 | $14.64 | +16.12% | 5 | Aug 11, 2026 | |
| CLLS Cellectis | Maintained: Buy | $9 | $3.40 | +164.71% | 2 | Aug 7, 2026 |
Sutro Biopharma
Aug 13, 2026
Maintained: Buy
Price Target: $56
Current: $20.45
Upside: +173.84%
Immunome
Aug 11, 2026
Maintained: Buy
Price Target: $36
Current: $27.57
Upside: +30.58%
Alpha Tau Medical
Aug 11, 2026
Maintained: Buy
Price Target: $17
Current: $14.64
Upside: +16.12%
Cellectis
Aug 7, 2026
Maintained: Buy
Price Target: $9
Current: $3.40
Upside: +164.71%